Perhaps it's just my impression, but with the growth in pharmacies and patients in Australia, the revenue growth looks anemic.
Not sure why revenues are only up 5.5% on the same quarter last year when they have a lot more pharmacies onboarded (even just chemist warehouse should have made some impression). As for delivery, pay in advance and telehealth, appreciate that none of that made it into this quarter (or minimal impact), but I'm hoping they have their pricing right as the combination of all of this should be driving at least 30-50% revenue growth off the low base revenues last year.
Its well overdue for some tangible results after all these investments and announcements IMO
Add to My Watchlist
What is My Watchlist?
